Nick Northcott

Nick founded and is the Managing Partner of the health & medical research consulting firm Chrysalis which has grown rapidly across Australia since 2016. Nick has extensive experience across health, academia, capital markets and industry, advising boards, CEOs, and executives to develop and execute strategies for growth, managing complex innovation and change projects, manage high-risk matters (e.g. investigations, disputes & governance issues) and to complete value-adding deals, including having raised over $100 million in the venture, philanthropic, grant and corporate funding. Nick is an active investor and experienced company director. In addition to being a Managing Partner of Chrysalis, Nick also sits on a number of portfolio company boards, including as Executive Chairman and Co-Founder of Med-Tech E.